Literature DB >> 25299917

Biopharmaceutical benchmarks 2014.

Gary Walsh1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25299917     DOI： 10.1038/nbt.3040

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  10 in total

1.  Biopharmaceutical benchmarks 2010.

Authors:  Gary Walsh
Journal:  Nat Biotechnol       Date:  2010-09       Impact factor: 54.908

2.  Biopharmaceutical benchmarks 2006.

Authors:  Gary Walsh
Journal:  Nat Biotechnol       Date:  2006-07       Impact factor: 54.908

Review 3.  Antibody-drug conjugates: current status and future directions.

Authors:  Heidi L Perez; Pina M Cardarelli; Shrikant Deshpande; Sanjeev Gangwar; Gretchen M Schroeder; Gregory D Vite; Robert M Borzilleri
Journal:  Drug Discov Today       Date:  2013-11-15       Impact factor: 7.851

4.  The special case of gene therapy pricing.

Authors:  Troyen A Brennan; James M Wilson
Journal:  Nat Biotechnol       Date:  2014-09       Impact factor: 54.908

5.  Sanofi to propel inhalable insulin Afrezza into market.

Authors:  Jim Kling
Journal:  Nat Biotechnol       Date:  2014-09       Impact factor: 54.908

Review 6.  Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.

Authors:  Kwang-Chul Kwon; Dheeraj Verma; Nameirakpam D Singh; Roland Herzog; Henry Daniell
Journal:  Adv Drug Deliv Rev       Date:  2012-10-23       Impact factor: 15.470

7.  Single-batch production of recombinant human polyclonal antibodies.

Authors:  Lars S Nielsen; Alexandra Baer; Christian Müller; Kristian Gregersen; Nina T Mønster; Søren K Rasmussen; Dietmar Weilguny; Anne B Tolstrup
Journal:  Mol Biotechnol       Date:  2010-07       Impact factor: 2.695

8.  Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques.

Authors:  Gene Garrard Olinger; James Pettitt; Do Kim; Cara Working; Ognian Bohorov; Barry Bratcher; Ernie Hiatt; Steven D Hume; Ashley K Johnson; Josh Morton; Michael Pauly; Kevin J Whaley; Calli M Lear; Julia E Biggins; Corinne Scully; Lisa Hensley; Larry Zeitlin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-15       Impact factor: 11.205

9.  Approval of the first biosimilar antibodies in Europe: a major landmark for the biopharmaceutical industry.

Authors:  Alain Beck; Janice M Reichert
Journal:  MAbs       Date:  2013-07-24       Impact factor: 5.857

10.  Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp.

Authors:  Xiangguo Qiu; Gary Wong; Jonathan Audet; Alexander Bello; Lisa Fernando; Judie B Alimonti; Hugues Fausther-Bovendo; Haiyan Wei; Jenna Aviles; Ernie Hiatt; Ashley Johnson; Josh Morton; Kelsi Swope; Ognian Bohorov; Natasha Bohorova; Charles Goodman; Do Kim; Michael H Pauly; Jesus Velasco; James Pettitt; Gene G Olinger; Kevin Whaley; Bianli Xu; James E Strong; Larry Zeitlin; Gary P Kobinger
Journal:  Nature       Date:  2014-08-29       Impact factor: 49.962
  10 in total
  204 in total

Review 1.  Pharmacokinetic and pharmacodynamic considerations for the next generation protein therapeutics.

Authors:  Dhaval K Shah
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-09-15       Impact factor: 2.745

2.  AB-Bind: Antibody binding mutational database for computational affinity predictions.

Authors:  Sarah Sirin; James R Apgar; Eric M Bennett; Amy E Keating
Journal:  Protein Sci       Date:  2015-11-06       Impact factor: 6.725

Review 3.  Protective alleles and modifier variants in human health and disease.

Authors:  Andrew R Harper; Shalini Nayee; Eric J Topol
Journal:  Nat Rev Genet       Date:  2015-10-27       Impact factor: 53.242

Review 4.  The transgenic animal platform for biopharmaceutical production.

Authors:  L R Bertolini; H Meade; C R Lazzarotto; L T Martins; K C Tavares; M Bertolini; J D Murray
Journal:  Transgenic Res       Date:  2016-01-28       Impact factor: 2.788

5.  A Modular Method for the High-Yield Synthesis of Site-Specific Protein-Polymer Therapeutics.

Authors:  Yan Pang; Jinyao Liu; Yizhi Qi; Xinghai Li; Ashutosh Chilkoti
Journal:  Angew Chem Int Ed Engl       Date:  2016-07-21       Impact factor: 15.336

6.  Construction, Purification, and Characterization of a Homodimeric Granulocyte Colony-Stimulating Factor.

Authors:  Gitana Mickiene; Indre Dalgediene; Zilvinas Dapkunas; Gintautas Zvirblis; Henrikas Pesliakas; Algirdas Kaupinis; Mindaugas Valius; Edita Mistiniene; Milda Pleckaityte
Journal:  Mol Biotechnol       Date:  2017-10       Impact factor: 2.695

Review 7.  Plant-made oral vaccines against human infectious diseases-Are we there yet?

Authors:  Hui-Ting Chan; Henry Daniell
Journal:  Plant Biotechnol J       Date:  2015-09-07       Impact factor: 9.803

8.  Impact of Glycosylation on the Local Backbone Flexibility of Well-Defined IgG1-Fc Glycoforms Using Hydrogen Exchange-Mass Spectrometry.

Authors:  Apurva S More; Ronald T Toth; Solomon Z Okbazghi; C Russell Middaugh; Sangeeta B Joshi; Thomas J Tolbert; David B Volkin; David D Weis
Journal:  J Pharm Sci       Date:  2018-05-08       Impact factor: 3.534

9.  Topical delivery of low-cost protein drug candidates made in chloroplasts for biofilm disruption and uptake by oral epithelial cells.

Authors:  Yuan Liu; Aditya C Kamesh; Yuhong Xiao; Victor Sun; Michael Hayes; Henry Daniell; Hyun Koo
Journal:  Biomaterials       Date:  2016-08-02       Impact factor: 12.479

10.  Comprehensive Glycoproteomic Analysis of Chinese Hamster Ovary Cells.

Authors:  Ganglong Yang; Yingwei Hu; Shisheng Sun; Chuanzi Ouyang; Weiming Yang; Qiong Wang; Michael Betenbaugh; Hui Zhang
Journal:  Anal Chem       Date:  2018-12-03       Impact factor: 6.986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.